The European Commission is in final stage talks with BioNTech-Pfizer over the supply of 200 million doses of their potential Covid-19 shot, with an option to buy another 100 million.
Spahn said he expects Germany will get up to 100 million doses of the BioNTech-Pfizer vaccine.
The companies said on Monday their vaccine was shown to be more than 90% effective, a major victory in the war against a virus that has killed over a million people and battered the world's economy.
Spahn reiterated that he does not expect the vaccine to be available before the first quarter of 2021 but added that he expected it to get approved quickly.
Spahn said news about the vaccine "was a light at the end of the tunnel" and raised the hope that next winter would not be as bad as this one.
He said the European Union was pursuing an extraordinary rolling review process meant to speed up approval of the shot, but stressed that this did not mean that standards would be lowered.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Six killed in Ukrainian bus accident in Poland
New Zealand to end virus lockdown on largest city
During tough times, dogs save the Queen: report
Swedish town in shock after stabbing attack
Farmers sound alarm over wave of suicides
Russia's Sputnik V vaccine takes key step to EU approval
Seven injured in 'suspected terrorist' stabbings in Sweden
Covax details rollout of 238mn vaccine doses
Ex-president Sarkozy is convicted of corruption